Abstract
During hyperthermic intraperitoneal chemotherapy (HIPEC), we observed a partial recovery from neuromuscular block in a hyperthermic patient after hours of monitored adequate surgical relaxation and continuous infusion of atracurium during normothermia. This recovery is indicative of the higher clearance of atracurium during hyperthermia. This case report emphasizes the clinical relevance of the well-known temperature dependence of the Hofmann elimination of atracurium. Moreover, this report illustrates the importance of monitoring muscle relaxation during HIPEC. Clinicians should be aware that the usual continuous infusion rate of atracurium at 0.3 mg·kg−1·h−1 may be inadequate in hyperthermic patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Flynn PJ, Hughes R, Walton B, Jothilingam S. Use of atracurium infusions for general surgical procedures including cardiac surgery with induced hypothermia. Br J Anaesth. 1983;55:135–138S.
Leslie K, Sessler DI, Bjorksten AR, Moayeri A. Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium. Anesth Analg. 1995;80:1007–1014.
Benzer A, Mitterschiffthaler G, Pomaroli A, Müller L. Atracurium in whole body hyperthermia. Anaesthesia. 1990;45:991.
Verwaal VJ, van Ruth S, de Bree E, van Slooten GW, van Tinteren H, Boot H, Zoetmulder FA. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–3743.
Fernandez-Trigo V, Stuart OA, Stephens AD, Hoover LD, Sugarbaker PH. Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C. Cancer Treat Res. 1996;81:51–61.
Viby-Mogensen J. Neuromuscular monitoring. In: Miller RD, editor. Miller’s anesthesia. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005. p. 1552–1553.
Caldwell JE, Heier T, Wright PMC, Lin S, McCarthy G, Szenohradszky J, Sharma ML, Hing JP, Scroeder M, Sessler DI. Temperature-dependent pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology. 2000;92:84–93.
Fisher DM, Canfell PC, Fahey MR, Rosen JI, Rupp SM, Sheiner LB, Miller RD. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organbased elimination. Anesthesiology. 1986;65:6–12.
Adachi T, Shinomura T, Nomura R. Duration of vecuronium-induced neuromuscular blockade is shortened during hyperthermic intraoperative intraperitoneal chemotherapy. Br J Anaesth. 2003;91:160–161.
Meyer RE, Page RL, Thrall DE, Dewhirst MW, Vose DL. Determination of continuous atracurium infusion rate in dogs undergoing whole-body hyperthermia. Cancer Res. 1986;46:5599–5601.
Kisor DF, Schmith VD. Clinical pharmacokinetics of cisatracurium besilate. Clin Pharmacokinet. 1999;36:27–40.
Author information
Authors and Affiliations
About this article
Cite this article
Jonker, G., Hoogenboom, L.J., van Ramshorst, B. et al. Atracurium during induced hyperthermia. J Anesth 23, 442–444 (2009). https://doi.org/10.1007/s00540-009-0773-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-009-0773-0